Diabetes mellitus after renal transplantation under FK 506 (tacrolimus) as primary immunosuppression
Tanabe, K.; Koga, S.; Takahashi, K.; Sonda, K.; Tokumoto, T.; Babazono, T.; Yagisawa, T.; Toma, H.; Kawai, T.; Fuchinoue, S.; Teraoka, S.; Ota, K.
Transplantation Proceedings 28(3): 1304-1305
1996
ISSN/ISBN: 0041-1345 PMID: 8658670 Document Number: 462677
Document emailed within 1 workday
Related Documents
Odocha, O.; McCauley, J.; Scantlebury, V.; Shapiro, R.; Carroll, P.; Jordan, M.; Vivas, C.; Fung, J.J.; Starzl, T.E. 1993: Posttransplant diabetes mellitus in African Americans after renal transplantation under FK 506 immunosuppression Transplantation Proceedings 25(4): 2433-2434Goffin, E.; Devogelaer, J.P.; Depresseux, G.; Squifflet, J.P.; Pirson, Y.; van Yperselede de Strihou, C. 2003: Evaluation of bone mineral density after renal transplantation under a tacrolimus-based immunosuppression: a pilot study Clinical Nephrology 59(3): 190-195
Andreu, J.; Campistol, J.M.; Oppenheimer, F.; Torregrosa, V.; Ricart, M.J.; Vilardell, J.; Carretero, P. 1994: Cyclosporine monotherapy as primary immunosuppression in renal transplantation--five-year experience Transplantation Proceedings 26(1): 337-340
Sindhi, R.; Webber, S.; Venkataramanan, R.; McGhee, W.; Phillips, S.; Smith, A.; Baird, C.; Iurlano, K.; Mazariegos, G.; Cooperstone, B.; Holt, D.W.; Zeevi, A.; Fung, J.J.; Reyes, J. 2001: Sirolimus for rescue and primary immunosuppression in transplanted children receiving tacrolimus Transplantation 72(5): 851-855
Tsai, M.-K.; Hu, R.-H.; Lee, C.-J.; Lee, P.-H. 2002: Efficacy of low-dose mycophenolate mofetil therapy for Taiwanese renal transplantation patients receiving primary cyclosporine immunosuppression Journal of the Formosan Medical Association 101(9): 616-621
Mesar, I.; Basić-Jukić, N.; Bubić-Filipi, L.; Kastelan, Z.; Bacak-Kocman, I.; Kes, P. 2011: Outcome of renal transplantation after tacrolimus switch to cyclosporine Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 65(4): 311-314
Kawaguchi, H.; Komatsu, Y.; Hattori, M.; Nagata, M.; Ito, K.; Takahashi, K.; Teraoka, S.; Toma, H.; Ota, K. 1989: Somatic growth and renal function in pediatric renal transplantation with alternate-day steroid immunosuppression using cyclosporine (CsA) in Japan Transplantation Proceedings 21(1 Part 2): 1698-1700
Gayowski, T.; Marino, I.R.; Singh, N.; Doyle, H.R.; Wagener, M.M.; Todo, S.; Fung, J.J.; Starzl, T.E. 1996: Orthotopic liver transplantation in U.S. veterans under primary tacrolimus immunosupression Surgical Technology International 5: 223-232
Wang, K.; Qu, Q.S.; Zhang, Y.X.; Miao, S.Z.; Jiang, X. 2016: Effects of Wuzhi capsule on blood concentration of tacrolimus after renal transplantation Journal of Biological Regulators and Homeostatic Agents 30(1): 155-159
Eckhoff, D.E.; McGuire, B.M.; Frenette, L.R.; Contreras, J.L.; Hudson, S.L.; Bynon, J.S. 1998: Tacrolimus (FK506) and mycophenolate mofetil combination therapy versus tacrolimus in adult liver transplantation Transplantation 65(2): 180-187
Bonomini, V.; Scolari, M.P.; Buscaroli, A.; Liviano D'Arcangelo, G.; Stefoni, S. 1997: Immunosuppression in renal transplantation International Journal of Artificial Organs 20(2): 73-75
Pilmore, H.L.; Faire, B.; Dittmer, I. 2001: Tacrolimus for the treatment of gout in renal transplantation: two case reports and review of the literature Transplantation 72(10): 1703-1705
Robles-Piedras, A.L.; Romano-Moreno, S.; Fuentes-Noriega, I.; Mancilla-Urrea, E.; González-López, E.H.; Domínguez-Ramírez, A. 2011: Relationship among changes in hematocrit, albumin and corticosteroid dose on the disposition of tacrolimus during the first six months following renal transplantation Proceedings of the Western Pharmacology Society 54: 30-32
Bechstein, W.O.; Neuhaus, P.; McMaster, P.; Calne, R.; Pichlmayr, R.; Otto, G.; Williams, R.; Ericzon, B.G.; Bismuth, H. 1996: Tacrolimus (FK 506) therapy is associated with a significant reduction in immunosuppressive treatment failures following primary liver transplantation Transplantation Proceedings 28(2): 1008-1010
Bosković, S.; Haracić, M. 1976: Steroid diabetes - very significant complication of immunosuppression following the kidney transplantation Medicinski Arhiv 30(3): 195-197
First, M.Roy. 2004: Tacrolimus based immunosuppression Journal of Nephrology 17(Suppl): S25-S31
McCune, T.R.; Thacker LR, I.I.; Peters, T.G.; Mulloy, L.; Rohr, M.S.; Adams, P.A.; Yium, J.; Light, J.A.; Pruett, T.; Gaber, A.O.; Selman, S.H.; Jonsson, J.; Hayes, J.M.; Wright, F.H.; Armata, T.; Blanton, J.; Burdick, J.F. 1998: Effects of tacrolimus on hyperlipidemia after successful renal transplantation: a Southeastern Organ Procurement Foundation multicenter clinical study Transplantation 65(1): 87-92
Morris-Stiff, G.; Khan, A.; Quiroga, I.; Baboo, R.; Jurewicz, W.A. 1999: Immunosuppression in renal transplantation. Meta-analysis should not have included one of the studies Bmj 319(7217): 1136; Author Reply 1137
Raine, A.E.; Carter, R.; Mann, J.I.; Chapman, J.R.; Morris, P.J. 1987: Increased plasma LDL cholesterol after renal transplantation associated with cyclosporine immunosuppression Transplantation Proceedings 19(1 Part 2): 1820-1821
Tax, W.J.; van de Heijden, H.M.; Willems, H.W.; Hoitsma, A.J.; Berden, J.H.; Capel, P.J.; Koene, R.A. 1987: Immunosuppression with monoclonal anti-T3 antibody (WT32) in renal transplantation Transplantation Proceedings 19(1 Part 3): 1905-1907